Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus- associated tuberculosis

Clinical Infectious Diseases

Volumn 25, Issue 5, 1997, Pages 1044-1047

  March, Francesca ^b   Garriga, Xavier ^b   Rodríguez, Purificatión ^b   Moreno, Carmen ^b   Garrigó, Montserrat ^b   Coll, Pere ^a   Prats, Guillem ^b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ETHAMBUTOL; FLUCONAZOLE; ISONIAZID; KETOCONAZOLE; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; DNA FINGERPRINTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME; TUBERCULOSIS; VIRUS INFECTION;

EID: 0030831049     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516065     Document Type: Article

References (25)

1. Pitchenik AE, Fertel D, Bloch AB. Mycobacterial disease: epidemiology, diagnosis, treatment and prevention. Clin Chest Med 1988;9:425-41.
2. Small PM, Scheeter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med 1991;324:289-94.
3. Snider DE Jr, Roper WL. The new tuberculosis. N Engl J Med 1992;326:703-5.
4. Iseman MD. Is standard chemotherapy adequate in tuberculosis patients infected with the HIV? [editorial]. Am Rev Respir Dis 1987;136:1326.
5. Sunderam G, Mangura BT, Lombardo JM, Reichman LB. Failure of "optimal" four-drug short-course tuberculosis chemotherapy in a compliant patient with human immunodeficiency virus. Am Rev Respir Dis 1987;136:1475-8.
6. Dylewski J, Thibert L. Failure of tuberculosis chemotherapy in a human immunodeficiency virus-infected patient. J Infect Dis 1990;162:778-9.
7. Godfrey-Fausset P, Stoker NG, Scott JAG, Pasvol G, Kelly P, Clancy L. DNA fingerprints of Mycobacterium tuberculosis do not change during the development of rifampicin resistance. Tuber Lung Dis 1993;74:240-3.
8. Bradford WZ, Martin JN, Reingold AL, Schecter GF, Hopewell PC, Small PM. The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet 1996;348:928-31.
9. Nolan CM, Williams DL, Cave MD, et al. Evolution of rifampin resistance in human immunodeficiency virus-associated tuberculosis. Am J Respir Crit Care Med 1995;152:1067-71.
10. Lutfey M, Della-Latta P, Kapur V, et al. Independent origin of monorifampin-resistant Mycobacterium tuberculosis in patients with AIDS. Am J Respir Crit Care Med 1996;153:837-40.
11. De Beenhouwer H, Lhiang Z, Jannes G, et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tuber Lung Dis 1995;76:425-30.
12. Small PM, van Embden JDA. Molecular epidemiology of tuberculosis. In: Bloom BR, ed. Tuberculosis: pathogenesis, protection, and control. Washington, DC: American Society for Microbiology Press, 1994:569-82.
13. Heifets LB. Rapid automated method (Bactec system) in clinical mycobacteriology. Semin Respir Infect 1986;1:242-9.
14. van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9.
15. Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1989;38:236-50.
16. Grange JM, Winstanley PA, Davies PD. Clinically significant drug interactions with antituberculosis agents. Drug Saf 1994;11:242-51.
17. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995;8:496-514.
18. Patel KB, Belmonte R, Crowe HM. Drug malabsorption and resistant tuberculosis in HIV-infected patients [letter]. N Engl J Med 1995;2:336-7.
19. Small PM, Shafer RW, Hopewell PC, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993;328:1137-44.
20. Lee BL, Safrin S. Interactions and toxicities of drugs used in patients with AIDS. Clin Infect Dis 1992;14:773-9.
21. Berning SE, Huitt GA, Iseman MD, Peloquin CA. Malabsorption of antituberculosis medications by a patient with AIDS [letter]. N Engl J Med 1992;327:1817-8.
22. Peloquin CA, MacPhee AA, Berning SE. Malabsorption of antimycobacterial medications [letter]. N Engl J Med 1993;329:1122-3.
23. Gillin JS, Shike M, Alcock N, et al. Malabsorption and mucosal abnormalities of the small intestine in the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:619-22.
24. Gordon SM, Horsburgh CR Jr, Peloquin CA, et al. Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease. J Infect Dis 1993;168:1559-62.
25. Mitchison DA. Drug resistance in mycobacteria. Br Med Bull 1984;40:84-90.